Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SNC-115 by Shanghai Simnova Biotechnology for Small-Cell Lung Cancer: Likelihood of Approval
SNC-115 is under clinical development by Shanghai Simnova Biotechnology and currently in Phase I for Small-Cell Lung Cancer. According to...
Data Insights
SNC-115 by Shanghai Simnova Biotechnology for Neuroendocrine Carcinoma: Likelihood of Approval
SNC-115 is under clinical development by Shanghai Simnova Biotechnology and currently in Phase I for Neuroendocrine Carcinoma. According to GlobalData,...